EP3464368
USE OF AN ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN LYMPHOMA TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.6.2017EP published:
28.6.2023EP application number:
17730629.7
EPO information:
European Patent Register
Max expiry date:
31.5.2037
Title in English:
USE OF AN ANTI-PD-1 ANTIBODY IN COMBINATION WITH AN ANTI-CD30 ANTIBODY IN LYMPHOMA TREATMENTLanguage of the patent:
English
Timeline
Today
1.6.2017EP application
28.6.2023EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Name:
Seagen Inc.Address:
21823 30th Drive S.E., Bothell, WA 98021, US
Inventor
Name:
FARSACI, BenedettoAddress:
Princeton New Jersey 08543, US
Name:
JOSEPHSON, NeilAddress:
Bothell Washington 98021, US
Name:
CAO, AnthonyAddress:
Sammamish Washington 98074, US
Name:
HEISER, RyanAddress:
Lake Stevens Washington 98258, US
Priority
Number:
201662344866 PDate:
2.6.2016Country:
US
Number:
201662382839 PDate:
2.9.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/00